Immuneel Therapeutics, backed by Eight Roads, secured Series B funding to advance its cancer care efforts. The company focuses on developing cell therapies for oncology. The funding will support clinical trials and manufacturing expansion for its pipeline of treatments.
Tap to vote and see what everyone thinks.
Perimeter Selected for INOVAIT Pilot Fund
Summary by ByteBrief